Focused Atorvastatin Therapy in Managed-Care Patients With Coronary Heart Disease and CKD
To access this article, please choose from the options below
Originally published online as doi:10.1053/j.ajkd.2008.11.025 on February 12, 2009.
For a list of ALLIANCE Investigators, please see reference 18.
PII: S0272-6386(08)01760-5
doi:10.1053/j.ajkd.2008.11.025
© 2009 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
Refers to article:
- Statin Effects in CKD: Is There a “Point of No Return”?
